Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastases of Central Nervous System”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04358666
What this trial is testing

Evaluation of the Best Treatment in Terms of Quality of Life for Patients Having a Brain Metastasis

Who this might be right for
Quality of LifeBrain Metastases
University Hospital, Caen 60
Very early researchStudy completedNCT02338037
What this trial is testing

Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain Tumors

Who this might be right for
Metastatic Malignant Neoplasm in the Adult BrainPrimary Brain Tumor
City of Hope Medical Center 8
Not applicableStudy completedNCT00159588
What this trial is testing

Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly?

Who this might be right for
Headache
Norwegian University of Science and Technology 64
Not applicableLooking for participantsNCT04073966
What this trial is testing

MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets

Who this might be right for
Brain MetastasesNeurocognitive DeficitWhite Matter Alterations+1 more
UNC Lineberger Comprehensive Cancer Center 20
Not applicableStudy completedNCT06132529
What this trial is testing

Evaluate Biomarker Signature to Predict the Persistence of Post-traumatic Headache

Who this might be right for
Post-Traumatic HeadacheHealthy
Mayo Clinic 151
Testing effectiveness (Phase 2)Study completedNCT02312622
What this trial is testing

Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer

Who this might be right for
Stage IV Non-small Cell Lung Cancer (NSCLC)Recurrent Non-small Cell Lung Cancer (NSCLC)Extensive-stage Small Cell Lung Cancer (SCLC)+3 more
Joel Neal 27
Not applicableLooking for participantsNCT07691255
What this trial is testing

MELanoma Brain Metastasis Treated With CYberknife

Who this might be right for
Melanoma (Skin Cancer)
European Institute of Oncology 50
Large-scale testing (Phase 3)UnknownNCT01509326
What this trial is testing

Chiropractic and Acupressure for Headaches

Who this might be right for
Cervicogenic HeadacheTension-type HeadacheMigraine Headache
Canadian Memorial Chiropractic College 36
Not applicableEnded earlyNCT00952185
What this trial is testing

Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more
City of Hope Medical Center 9
Not applicableStudy completedNCT04401878
What this trial is testing

SGB in Management of Patients With PDPH Using TCD

Who this might be right for
Post-Dural Puncture Headache
Zagazig University 120
Testing effectiveness (Phase 2)WithdrawnNCT03696485
What this trial is testing

Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMS

Who this might be right for
Secondary Progressive Multiple Sclerosis (SPMS)
Stem Cell Medicine Ltd.
Not applicableStudy completedNCT06459726
What this trial is testing

Effects of Shi Style Cervical Mobilization Versus SNAGS in Patients With Cervicogenic Headache

Who this might be right for
Cervicogenic Headache
Riphah International University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06047379
What this trial is testing

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Who this might be right for
Diffuse Astrocytoma, IDH-MutantGlioblastoma, IDH-wildtypeBrain Metastases, Adult+18 more
Neonc Technologies, Inc. 134
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06374888
What this trial is testing

Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases

Who this might be right for
Her2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastasis
Convalife (Shanghai) Co., Ltd. 28
Not applicableLooking for participantsNCT07801274
What this trial is testing

Postoperative Edge (RapidArc) Stereotactic Body Radiotherapy for Spinal Metastases

Who this might be right for
Spinal MetastasesMetastatic Epidural Spinal Cord CompressionSpinal Cord Compression
Tianjin Medical University Cancer Institute and Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT05948813
What this trial is testing

TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases

Who this might be right for
NSCLCEGFR Activating MutationBrain Metastases
TYK Medicines, Inc 420
Not applicableUnknownNCT01503827
What this trial is testing

Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma

Who this might be right for
Metastatic Melanoma
Melanoma and Skin Cancer Trials Limited 220
Not applicableStudy completedNCT02956291
What this trial is testing

Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors

Who this might be right for
Brain Tumor
Case Comprehensive Cancer Center 170
Testing effectiveness (Phase 2)Looking for participantsNCT05909618
What this trial is testing

Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases

Who this might be right for
Advanced GlioblastomaMetastatic Melanoma in the Central Nervous SystemMGMT-Unmethylated Glioblastoma
Sheba Medical Center 33
Testing effectiveness (Phase 2)WithdrawnNCT03868423
What this trial is testing

Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers

Who this might be right for
Advanced Malignant NeoplasmALK Fusion Protein ExpressionALK Gene Amplification+8 more
Sameek Roychowdhury
Next Page